MyAverix Finance MyAverix Finance

JK · Healthcare

Penta Valent (PEVE)

Pharmaceutical Retailers

Penta Valent (PEVE) is listed on JK in the Healthcare sector. Industry: Pharmaceutical Retailers. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for PEVE

P/E ratio
18.00

Penta Valent (PEVE) — FAQ

What is PEVE's P/E ratio?

The price-to-earnings (P/E) ratio for Penta Valent (PEVE) is 18.00 (data as of 2026-05-24).

Does Penta Valent pay a dividend?

Dividend yield is not available in the current snapshot for Penta Valent (PEVE). Check the MyAverix Finance app for the latest dividend data.

What sector is Penta Valent in?

Penta Valent (PEVE) is classified in the Healthcare sector (Pharmaceutical Retailers industry).

What exchange is PEVE listed on?

PEVE is listed on JK.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play